Summary of findings for the main comparison. Repeat midurethral tape (any type) versus any other non‐tape surgical treatment (e.g. traditional sling, colposuspension, injectables).
Repeat midurethral tape (any type) versus any other non‐tape surgical treatment (e.g. traditional sling, colposuspension, injectables) for recurrent stress urinary incontinence in women with failed minimally invasive midurethral tape surgery | ||||||
Patient or population: women with recurrent stress urinary incontinence after failed minimally invasive midurethral tape surgery Settings: secondary or tertiary urogynaecology centre Intervention: repeat midurethral tape (any type) Comparison: any other non‐tape surgical treatment (e.g. traditional sling, colposuspension, injectables) | ||||||
Outcomes | Illustrative comparative risks* (95% CI) | Relative effect (95% CI) | No of Participants (studies) | Certainty of the evidence (GRADE) | Comments | |
Assumed risk | Corresponding risk | |||||
Risk with other non‐tape surgical treatment | Risk with repeat midurethral sling | |||||
Number of women whose incontinence was improved or cured ‐ assessed with validated incontinence questionnaires | ‐ | ‐ | ‐ | ‐ | ‐ | No studies identified |
Objective cure rates in the longer‐term ‐ more than 12 months, assessed with urodynamics | ‐ | ‐ | ‐ | ‐ | ‐ | No studies identified |
General health status measures ‐ e.g. Short‐Form 36 | ‐ | ‐ | ‐ | ‐ | ‐ | No studies identified |
Condition‐specific instruments designed to assess incontinence ‐ e.g. BFLUTS | ‐ | ‐ | ‐ | ‐ | ‐ | No studies identified |
Repeat continence surgery | ‐ | ‐ | ‐ | ‐ | ‐ | No studies identified |
Adverse events | ‐ | ‐ | ‐ | ‐ | ‐ | No studies identified |
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: Confidence interval; BFLUTS: Bristol Female Lower Urinary Tract Symptoms questionnaire | ||||||
GRADE Working Group grades of evidence High certainty: Further research is very unlikely to change our confidence in the estimate of effect. Moderate certainty: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low certainty: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low certainty: We are very uncertain about the estimate. |